Form 4: Celcuity Inc. Director Sells Shares Under 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Celcuity Inc. Director David Dalvey reported a sale of 25,000 shares of common stock for $140.68 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Director David Dalvey of Celcuity Inc. sold 25,000 shares of common stock.
- The sale occurred on May 4, 2026, at a price of $140.68 per share.
- These shares were sold as part of a Rule 10b5-1 trading plan established by Brightstone Venture Capital Fund, LP on August 19, 2025.
- Following the transaction, Dalvey beneficially owns 65,000 shares, held indirectly through Brightstone Venture Capital Fund, LP, where he serves as General Partner.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the sale was conducted under a pre-established Rule 10b5-1 plan, which is a standard and legally protected method for insiders to trade securities.
Negatives
- Director David Dalvey sold a significant number of shares (25,000) from his beneficial ownership.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing.
Management Comments
- The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Brightstone Venture Capital Fund, LP on August 19, 2025.
- The reporting person is the General Partner of Brightstone.
Industry Context
StockSavvy.ai notes that Form 4 filings, particularly those involving Rule 10b5-1 plans, are common for insiders to diversify holdings or manage personal finances in a pre-determined manner, aiming to avoid accusations of insider trading. The execution of such a plan by a director of Celcuity Inc. is a standard disclosure practice.
Stakeholder Impact
- Shareholders may view the sale of shares by a director with caution, although the Rule 10b5-1 plan mitigates concerns about insider trading.
- The transaction does not directly impact employees, customers, suppliers, or creditors based on the information provided.
Key Dates
| Date | Description |
|---|---|
| 08/19/2025 | Date Rule 10b5-1 trading plan was adopted by Brightstone Venture Capital Fund, LP. |
| 05/04/2026 | Transaction date for the sale of common stock. |
| 05/06/2026 | Date the signature was effective as Attorney-in-Fact. |
Keywords
Celcuity Inc., CELC, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Director Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.